Serendipitous discovery of aryl boronic acids as β-lactamase inhibitors.

Bioorg Med Chem Lett

Discovery Chemistry, Merck & Co., Inc., Kenilworth, NJ 07033, USA. Electronic address:

Published: January 2020

High throughput screening for β-lactamase inhibitors afforded biphenyl hits such as 1. Hit confirmation and X-ray soaking experiments with Pseudomonas Aeruginosa AmpC enzyme led to the identification of an aryl boronic acid-serine complex 4, which was formed from phenyl boronic acid 8 (an impurity in compound 1) and ethylene glycol (the cryoprotectant in the soaking experiment).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2019.126795DOI Listing

Publication Analysis

Top Keywords

aryl boronic
8
β-lactamase inhibitors
8
serendipitous discovery
4
discovery aryl
4
boronic acids
4
acids β-lactamase
4
inhibitors high
4
high throughput
4
throughput screening
4
screening β-lactamase
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!